| BIOCELTIX S.A. ZY -,10 |
| Polen |
| Gesundheit |
| PLBCLTX00019 / A3C7NH |
| XI3 (Frankfurt) |
| FRA:XI3, ETR:XI3, XI3:GR |
| - |
| https://bioceltix.com/ |
|
Bioceltix S.A. is a biotechnology company focused on developing and commercializing innovative veterinary biomedicines. Its primary function is to enhance animal health through products designed for companion animals and livestock. Leveraging advance..
>Volltext.. |
| 100.57 Mio. EUR |
| 95.07 Mio. EUR |
| - |
| -3.99 Mio. EUR |
| -3.55 Mio. EUR |
| -0.72 EUR |
| 0.1 Mio. EUR |
| 5.7 Mio. EUR |
| -2.78 Mio. EUR |
| 8.06 |
| - |
| 4.59% |
| - |
| - |
| - |
| - |
| BIOCELTIX |
| 05.04.26 |
|